Virtus Medical Group announced that it has received funds in a round of funding led by new investor Shanghai Healthcare Capital Partnership (Limited Partnership) on March 14, 2024. The transaction included participation from new investors Mitsui & Co., Ltd. and Shanghai MediTrust Health Technology Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7,640 JPY | -1.36% | +1.08% | +44.21% |
05-03 | Mitsui & Co Completes 109 Billion Yen Sale of Paiton Energy | MT |
05-03 | Mitsui & Co to Repurchase and Cancel Up to 40 Million Shares | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.21% | 75.08B | |
+23.06% | 68.97B | |
+0.39% | 38.73B | |
+35.89% | 33.82B | |
+29.10% | 31.55B | |
+18.30% | 23.07B | |
+16.06% | 18.09B | |
-0.75% | 13.26B | |
+31.81% | 6.02B | |
+0.18% | 5.8B |
- Stock Market
- Equities
- 8031 Stock
- News Mitsui & Co., Ltd.
- Virtus Medical Group announced that it has received funding from Shanghai Healthcare Capital Partnership (Limited Partnership), Mitsui & Co., Ltd., Shanghai MediTrust Health Technology Co., Ltd.